Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations
Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), has appointed Tracy Krumme as Senior Vice President of Investor Relations, replacing Hima Inguva. Reporting to CFO Jill McConnell, Krumme will lead the company's global investor relations strategy.
Krumme brings over 30 years of experience in investor relations and capital markets, with significant expertise in the CRO, life sciences, and healthcare sectors. Her previous roles include head of investor relations at PPD (acquired by Thermo Fisher Scientific), Galderma, and Nuance Communications (acquired by Microsoft). She has worked alongside Fortrea's current CEO Anshul Thakral during her tenure at PPD.
Fortrea (Nasdaq: FTRE), un'importante organizzazione globale di ricerca a contratto (CRO), ha nominato Tracy Krumme come Senior Vice President delle Relazioni con gli Investitori, sostituendo Hima Inguva. Riportando al CFO Jill McConnell, Krumme guider脿 la strategia globale di relazioni con gli investitori dell'azienda.
Krumme vanta oltre 30 anni di esperienza nelle relazioni con gli investitori e nei mercati finanziari, con una significativa competenza nei settori CRO, scienze della vita e sanit脿. I suoi ruoli precedenti includono la direzione delle relazioni con gli investitori presso PPD (acquisita da Thermo Fisher Scientific), Galderma e Nuance Communications (acquisita da Microsoft). Durante il suo periodo in PPD ha collaborato con l'attuale CEO di Fortrea, Anshul Thakral.
Fortrea (Nasdaq: FTRE), una destacada organizaci贸n global de investigaci贸n por contrato (CRO), ha nombrado a Tracy Krumme como Vicepresidenta Senior de Relaciones con Inversionistas, reemplazando a Hima Inguva. Reportando a la CFO Jill McConnell, Krumme liderar谩 la estrategia global de relaciones con inversionistas de la compa帽铆a.
Krumme aporta m谩s de 30 a帽os de experiencia en relaciones con inversionistas y mercados de capital, con una considerable experiencia en los sectores CRO, ciencias de la vida y salud. Sus cargos anteriores incluyen jefa de relaciones con inversionistas en PPD (adquirida por Thermo Fisher Scientific), Galderma y Nuance Communications (adquirida por Microsoft). Durante su tiempo en PPD trabaj贸 junto con el actual CEO de Fortrea, Anshul Thakral.
Fortrea (Nasdaq: FTRE)電� 旮�搿滊矊 靹犽弰 瓿勳暯 鞐瓣惮 旮瓣磤(CRO)鞙茧, 韸鸽爤鞚挫嫓 韥熂(Tracy Krumme)鞚� 韴瀽鞛� 甏�瓿� 靾橃劃 攵�靷灔鞙茧 鞛勲獏頃橃棳 頌堧 鞛夑惮氚�(Hima Inguva)毳� 雽�觳错枅鞀惦媹雼�. 韥熂鞚� CFO 歆� 毵レ綌雱�(Jill McConnell)鞐愱矊 氤搓碃頃橂┌, 須岇偓鞚� 旮�搿滊矊 韴瀽鞛� 甏�瓿� 鞝勲灥鞚� 鞚措亴瓴� 霅╇媹雼�.
韥熂鞚� 韴瀽鞛� 甏�瓿� 氚� 鞛愲掣 鞁滌灔 攵勳暭鞐愳劀 30雲� 鞚挫儊鞚� 瓴诫牓鞚� 氤挫湢頃橁碃 鞛堨溂氅�, CRO, 靸濍獏瓿柬暀 氚� 項姢旒�鞏� 攵勳暭鞐� 雽�頃� 旯婌潃 鞝勲靹膘潉 臧栰稊瓿� 鞛堨姷雼堧嫟. 鞚挫爠鞐愲姅 PPD(韰岆ゴ氇� 頂检厰 靷澊鞏疙嫲頂届棎 鞚胳垬霅�), 臧堧崝毵�, 雸勳柛鞀� 旎る雼堨紑鞚挫厴歃�(毵堨澊韥靻岉攧韸胳棎 鞚胳垬霅�)鞐愳劀 韴瀽鞛� 甏�瓿� 毂呾瀯鞛愲 攴茧頄堨姷雼堧嫟. PPD 鞛 鞁滌爤 順勳灛 Fortrea CEO鞚� 鞎堨姁 韮�韥瀯(Anshul Thakral)瓿� 頃粯 鞚柬暅 瓴巾棙鞚� 鞛堨姷雼堧嫟.
Fortrea (Nasdaq : FTRE), une organisation mondiale de recherche sous contrat (CRO) de premier plan, a nomm茅 Tracy Krumme au poste de vice-pr茅sidente principale des relations avec les investisseurs, en remplacement de Hima Inguva. Relevant de la directrice financi猫re Jill McConnell, Krumme dirigera la strat茅gie mondiale des relations avec les investisseurs de l'entreprise.
Krumme apporte plus de 30 ans d'exp茅rience dans les relations avec les investisseurs et les march茅s financiers, avec une expertise significative dans les secteurs CRO, des sciences de la vie et de la sant茅. Ses pr茅c茅dents postes incluent responsable des relations avec les investisseurs chez PPD (acquise par Thermo Fisher Scientific), Galderma et Nuance Communications (acquise par Microsoft). Elle a travaill茅 aux c么t茅s de l'actuel PDG de Fortrea, Anshul Thakral, pendant son mandat chez PPD.
Fortrea (Nasdaq: FTRE), ein f眉hrendes globales Auftragsforschungsunternehmen (CRO), hat Tracy Krumme als Senior Vice President f眉r Investor Relations ernannt und ersetzt damit Hima Inguva. Krumme berichtet an CFO Jill McConnell und wird die globale Investor-Relations-Strategie des Unternehmens leiten.
Krumme bringt 眉ber 30 Jahre Erfahrung in den Bereichen Investor Relations und Kapitalm盲rkte mit, mit umfangreicher Expertise in den Branchen CRO, Life Sciences und Gesundheitswesen. Zu ihren fr眉heren Positionen z盲hlen Leiterin der Investor Relations bei PPD (眉bernommen von Thermo Fisher Scientific), Galderma und Nuance Communications (眉bernommen von Microsoft). W盲hrend ihrer Zeit bei PPD arbeitete sie mit Fortreas aktuellem CEO Anshul Thakral zusammen.
- Appointment of seasoned executive with over 30 years of relevant industry experience
- New SVP has prior working relationship with current CEO from PPD
- Brings specific expertise in CRO, life sciences, and healthcare sectors
- None.
DURHAM, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) -- 听(狈补蝉诲补辩: FTRE), a leading global contract research organization (CRO), today announced the appointment of Tracy Krumme as senior vice president, investor relations, succeeding Hima Inguva in this role, who has decided to pursue other career opportunities. Krumme will report to Chief Financial Officer, Jill McConnell, and lead Fortrea鈥檚 global investor relations strategy, serving as a key liaison to the investment community.
鈥淭racy is a seasoned executive with the strategic mindset and investor acumen needed as Fortrea enters its next chapter,鈥� said McConnell. 鈥淪he brings not only deep capital markets expertise but also integrity, insight and a strong track record of supporting strategic transformation and growth. We鈥檙e excited to welcome her to the team. I also would like to express my sincere appreciation to Hima Inguva, who has led Fortrea鈥檚 Investor Relations since our founding as a company. We wish her every success in her next chapter.鈥�
Krumme brings more than three decades of investor relations and capital markets experience to Fortrea, with expertise across the CRO, life sciences and healthcare sectors. She previously served as head of investor relations at PPD, a leading CRO acquired by Thermo Fisher Scientific, where she worked alongside Fortrea鈥檚 CEO Anshul Thakral; Galderma, a global dermatology company; and Nuance Communications, a provider of healthcare AI solutions acquired by Microsoft. Most recently, she was senior vice president, head of investor relations and corporate communications at Bitfarms, a global energy and compute infrastructure company. Earlier in her career, she led investor relations at Luxoft, acquired by DXC Technology, and NCR Corporation, and held roles as an equity research analyst at Sandler O鈥橬eill & Partners and in corporate finance at Prudential Securities and Kidder, Peabody International in London.
鈥淚鈥檓 excited to join Fortrea at such a pivotal moment in its evolution as an independent, pure-play CRO,鈥� said Krumme. 鈥淚 look forward to working with the leadership team to articulate Fortrea鈥檚 vision and value proposition to the investment community as we deliver differentiated solutions to our customers and generate long-term value for shareholders.鈥�
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea鈥檚 solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at聽聽and follow us on聽听补苍诲听聽(formerly Twitter).
Fortrea Contacts:
Tracy Krumme (Investors) 鈥� 984-385-6707,
Hima Inguva (Investors) 鈥� 877-495-0816,
Sue Zaranek (Media) 鈥� 919-943-5422,聽
Kate Dillon (Media) 鈥� 646-818-9115,
FAQ
Who is Tracy Krumme and what is her new role at Fortrea (FTRE)?
What is Tracy Krumme's experience in the healthcare and CRO industry?
Who did Tracy Krumme replace as SVP of Investor Relations at Fortrea?
Who will Tracy Krumme report to at Fortrea (FTRE)?
